…16 Mar 2026 10:02
Well this has given me a good laugh , Is it a wind up !!! The only reason PYC exists is because the directors involved have vast experience and industry knowledge and add credibility along with existing relationships with pharma
These muppets are talking about replacing all that and what do they offer ? The new guy seems to have an Ego and a half to do what he’s doing. How on earth will he run this company and why would anyone deal with him ? It’s like Donald trump taking over my two hospitality businesses and realising he’s needed on the pot wash.
I’m going to inject a bit of realism here , I actually think the board could do with a money person on the board but to replace them all ? They have actually done a good job controlling costs and trying their hardest to develop new business.
Raising 400-500 K a year is peanuts for a company with a growth model and for AIM
The issue is they haven’t quite managed to forge a viable business and that’s not through want of trying.
Simply put if you put these clueless individuals in charge contacts will dry up and the company will wind up gone , these guys have zero experience in this field and think they are big shots , they are not , The smartest thing you can do right now is sell out into their bluster and ramping. Because this is over from here if they get in.